Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

Quintiles president to chair Idis

September 13, 2013 Manufacturing and Production, Research and Development, Sales and Marketing IDIS, Quintiles, thomis

Former Quintiles president Jeff Thomis has been appointed to the role of chairman at Idis. In his new role, Thomis …
Appointment

Bayer partners with US academics

September 13, 2013 Research and Development, Sales and Marketing Bayer, Cancer, broad, oncology

Bayer HealthCare and a prestigious US academic institution have signed a five-year deal to find new oncology treatments. The German …
News

Hunt: GPs to care for elderly

September 12, 2013 Sales and Marketing GP, Hunt, NHS, elderly

Health secretary Jeremy Hunt says that GPs are in line to become the named clinician responsible for elderly people’s care …
News

Sanofi withdraws lixisenatide US application

September 12, 2013 Sales and Marketing FDA, Lixisenatide, Sanofi, diabetes, elixa

In a blow to its diabetes pipeline, Sanofi has withdrawn a new drug application (NDA) for lixisenatide in the US …
News

Amicus links with Biogen Idec

September 12, 2013 Research and Development, Sales and Marketing Amicus, Biogen IDEC, Parkinson's

Amicus Therapeutics and Biogen Idec have signed a collaboration agreement which will see them look for novel small molecules for …
News

LipoScience reappoints chief medical officer

September 12, 2013 Manufacturing and Production, Research and Development, Sales and Marketing cromwell, liposcience

Diagnostics firm LipoScience has once again hired William Cromwell to be its chief medical officer. He joins the company for …
Appointment

UK trial rules tightened up

September 11, 2013 Research and Development, Sales and Marketing all trials, hra, transparency

Anyone wanting to conduct clinical trials in the UK will have to register their research in order to receive a …
News

AstraZeneca pays Merck for cancer drug

September 11, 2013 Sales and Marketing AstraZeneca, Cancer, Merck, WEE1

AstraZeneca is to pay $50 million up front to get a worldwide licensing deal for one of Merck’s investigational drugs …
News

NHS Confederation chief executive quits to be a consultant

September 11, 2013 Medical Communications, Sales and Marketing Mike Farrar, NHS, scandal

Mike Farrar is to stand down as chief executive of the NHS Confederation at the end of the month in …
News

Biogen signs neurology deal

September 11, 2013 Research and Development, Sales and Marketing Biogen IDEC, Isis, antisense, neurology

Biogen Idec and Isis Pharmaceuticals have entered their fourth partnership in two years in a deal that will see the …
News

Regeneron appoints senior VP from Pfizer

September 11, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pfizer, Regeneron, landry

Regeneron Pharmaceuticals has hired Robert Landry from Pfizer to be its senior vice president and chief financial officer.  Landry will …
Appointment

Hospira’s Inflectra approved in Europe

September 10, 2013 Research and Development, Sales and Marketing Hospira, Janssen, Remicade, biosimilars, inflectra

Hospira has been the first firm to meet the European Commission’s approval for a biosimilar monoclonal antibody therapy with its …
News

EFPIA slams EMA data proposals

September 10, 2013 Research and Development, Sales and Marketing AZ, EFPIA, EMA, GSK, Pfizer, Roche

The intense debate over how pharma should make trial data available has taken another turn as a major European industry …
News

GSK completes £1.35 billion Suntory deal

September 10, 2013 Sales and Marketing GSK, Suntory, lucozade, ribena

GlaxoSmithKline has confirmed it is to sell Lucozade and Ribena to Japanese drinks giant Suntory Beverage & Food for £1.35 …
News

Robert Brooks joins Achilles from Abbott

September 10, 2013 Manufacturing and Production, Research and Development, Sales and Marketing AbbVie, Abbott, achilles, brook

Supply chain firm Achilles has hired Dr Robert Brooks to be a Business Development director from pharma firm Abbott. Brooks …
Appointment
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026